Newsbenzinga
FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults & Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…